Abstract:OBJECTIVETo investigate the expression of miR-130b in human hepatocellular carcinoma (HCC) and its correlations with clinical-pathological features.METHODSReal-time quantitative PCR (qRT-PCR) was applied to detect the expression of miR-130b in HCC tissues (n=86), matched normal tumor-adjacent tissues and 5 HCC cell lines (LO2 human normal hepatocytes, HepG2, Hep3B, SMMC-7721, Hu7 cells). The expressions of peroxisome proliferator-activated receptor γ (PPARγ), E-cadherin and vimentin were measured by immunohistochemistry. miR-130b inhibitor synthesized artificially was transfected into SMMC-7721 cells in vitro. Cell invasion was analyzed by Transwell(TM) assay. The expressions of PPARγ, E-cardhern and vimentin in SMMC-7721 cells after transfected with miR-130b inhibitor and PPARγ siRNA were detected by qRT-PCR and Western blotting.RESULTSThe expression of miR-130b mRNA in HCC tissues was significantly higher than that in matched normal tumor-adjacent tissues. Clinical analysis indicated that high expression of miR-130b was prominently correlated with venous infiltration, high Edmondson-Steiner grading and advanced tumor node metastasis (TNM) stage. Elevated miR-130b expression was observed in all HCC cell lines (HepG2, SMMC-7721, Huh7 and Hep3B) as compared with that in LO2 nontransformed hepatic cell line. Furthermore, there was an inverse correlation between miR-130b and E-cadherin as well as between miR-130b and PPARγ, and a positive correlation between miR-130b and vimentin was demonstrated in HCC tissues. miR-130b inhibitor could significantly increase the expression of PPARγ and E-cadherin, but decrease the expression of vimentin in SMMC-7721 cells, meanwhile it suppressed the migration and invasion of SMMC-7721 cells. In addition, the down-regulation of PPARγ expression by PPARγ siRNA partially abrogated the above effect of miR-130b on HCC cells.CONCLUSIONThe expression of miR-130b in HCC tissues is significantly higher than that in tumor-adjacent tissues. The increased expression of miR-130b is related with the malignant manifestations of HCC. miR-130b may promote HCC cell invasion by inhibiting PPARγ expression and inducing epithelial-mesenchymal transition.

Methylation-Mediated Repression of Microrna 129-2 Enhances Oncogenic Sox4 Expression in Hcc

Methylation-mediated Repression of Microrna-129-2 Suppresses Cell Aggressiveness by Inhibiting High Mobility Group Box 1 in Human Hepatocellular Carcinoma.

MicroRNA-302d Downregulates TGFBR2 Expression and Promotes Hepatocellular Carcinoma Growth and Invasion.

Methylation-associated Silencing of Microrna-129-3p Promotes Epithelial-Mesenchymal Transition, Invasion and Metastasis of Hepatocelluar Cancer by Targeting Aurora-A.

miR-101 is down-regulated by the hepatitis B virus x protein and induces aberrant DNA methylation by targeting DNA methyltransferase 3A

Mir-184 Post-Transcriptionally Regulates SOX7 Expression and Promotes Cell Proliferation in Human Hepatocellular Carcinoma

Aberrant Expression of Microrna 155 May Accelerate Cell Proliferation by Targeting Sex-Determining Region Y Box 6 in Hepatocellular Carcinoma

MicroRNA-1296 Inhibits Metastasis and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting SRPK1-mediated PI3K/AKT Pathway

Hypomethylation of the Hsa-Mir-191 Locus Causes High Expression of Hsa-Mir-191 and Promotes the Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma

Epigenetic silencing of miR-144/451a cluster contributes to HCC progression via paracrine HGF/MIF-mediated TAM remodeling

Regulation of microRNA-129-2 expression by cytosine-phosphoric acid-guanine motif island methylation and its effect on the proliferation and colony formation in renal cell carcinoma

Sox15 Methylation Inhibits Cell Proliferation Through Wnt Signaling in Hepatocellular Carcinoma

The chromosome 19 microRNA cluster, regulated by promoter hypomethylation, is associated with tumour burden and poor prognosis in patients with hepatocellular carcinoma

Upregulation of Mir-362-3p Modulates Proliferation and Anchorage-Independent Growth by Directly Targeting Tob2 in Hepatocellular Carcinoma

The Dysregulation of SOX Family Correlates with DNA Methylation and Immune Microenvironment Characteristics to Predict Prognosis in Hepatocellular Carcinoma

miR-1-3p suppresses proliferation of hepatocellular carcinoma through targeting SOX9.

Exosomal MiR-1290 Promotes Angiogenesis of Hepatocellular Carcinoma via Targeting SMEK1

[The Expression and Clinopathological Significance of Mir-130B in Human Hepatocellular Carcinoma].

Epigenetic modification of MiR-429 promotes liver tumour-initiating cell properties by targeting Rb binding protein 4.

Advances in the Research of Reciprocal Interconnections Between DNA Methylation and Microrna Regulation in Hepatocellular Carcinoma

MicroRNA-196a/-196b regulate the progression of hepatocellular carcinoma through modulating the JAK/STAT pathway via targeting SOCS2